# Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM

> **NCT05709938** · PHASE4 · COMPLETED · sponsor: **King Edward Medical University** · enrollment: 68 (actual)

## Conditions studied

- To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children

## Interventions

- **DRUG:** Glargine and regular insulin versus NPH and regular insulin

## Key facts

- **NCT ID:** NCT05709938
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2021-01-05
- **Final completion:** 2021-04-20
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2023-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709938, "Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05709938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*